225Ac α-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor Receptor 2-Expressing Breast Cancer.
Saved in:
| Title: | 225Ac α-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor Receptor 2-Expressing Breast Cancer. |
|---|---|
| Authors: | Rinne SS; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, New York.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Burnes Vargas D; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, New York., Seo S; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Veach D; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiology, Weill Cornell Medicine, New York, New York., McDevitt MR; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiology, Weill Cornell Medicine, New York, New York., Vaughn BA; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, New York.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Xu H; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Guo HF; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Fung EK; Department of Medical Physics, Weill Cornell Medicine, New York, New York., de Stanchina E; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York; and., Miranda IC; Laboratory of Comparative Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, and Rockefeller University, New York, New York., Larson SM; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Cheung NKV; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Cheal SM; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, New York; smc4002@med.cornell.edu.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2025 Nov 03; Vol. 66 (11), pp. 1714-1721. Date of Electronic Publication: 2025 Nov 03. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
